GSK-583

CAS No. 1346547-00-9

GSK-583 ( GSK583;GSK 583 )

Catalog No. M11400 CAS No. 1346547-00-9

A potent, selective and orally bioavailable RIPK2 kinase inhibitor with IC50 of 5 nM and 2 nM for human and rat RIP2, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 59 In Stock
5MG 106 In Stock
10MG 181 In Stock
25MG 302 In Stock
50MG 441 In Stock
100MG 654 In Stock
500MG 1368 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GSK-583
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective and orally bioavailable RIPK2 kinase inhibitor with IC50 of 5 nM and 2 nM for human and rat RIP2, respectively.
  • Description
    A potent, selective and orally bioavailable RIPK2 kinase inhibitor with IC50 of 5 nM and 2 nM for human and rat RIP2, respectively; displays robust selectivity against p38α and VEGFR2, and shows little or no inhibition of RIP3-dependent necroptotic cell death; potently and dose dependently inhibits MDP-stimulated TNFα production in human monocytes and human whole bolld with IC50 of 8 nM and 237 nM, respectively; inhibits MDP-induced inflammatory responses in vivo.
  • Synonyms
    GSK583;GSK 583
  • Pathway
    Apoptosis
  • Target
    RIP kinase
  • Recptor
    RIP1;RIP3
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    1346547-00-9
  • Formula Weight
    398.45
  • Molecular Formula
    C20H19FN4O2S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 37 mg/mL
  • SMILES
    FC1=CC2=C(NN=C2NC3=CC=NC4=CC=C(S(=O)(C(C)(C)C)=O)C=C34)C=C1
  • Chemical Name
    4-Quinolinamine, 6-[(1,1-dimethylethyl)sulfonyl]-N-(5-fluoro-1H-indazol-3-yl)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Haile PA, et al. J Med Chem. 2016 May 26;59(10):4867-80.
molnova catalog
related products
  • HS-1371

    HS-1371 (HS1371) is a novel potent, ATP-competitive receptor-interacting protein kinase-3 (RIP3 or RIPK3 kinase) inhibitor with IC50 of 20.8 nM.

  • RIPK2 inhibitor 1

    RIPK2 inhibitor 1 is a novel potent, selective RIPK2 inhibitor with IC50 of 5-10nM.

  • RIPK2-IN-8

    A potent, selective, orally available RIPK2 inhibitor with IC50 of 3 nM.